Project Details
Description
The aim of the proposal is to unravel the epigenetic determinants mediating the immune effects of AID at the systemic level and at the tumor site, in patients with early stages of cancer. Primary aims: to analyse in the clinical setting AID-mediated modulation of immune cell profile and investigate the underlying epigenomic mechanisms in depth by sensitive and novel multi-omic approaches. Secondary aim: to identify and evaluate new epigenetic biomarkers and targets with translational potential.
Acronym | DICE |
---|---|
Status | Active |
Effective start/end date | 1/05/24 → 30/04/27 |
Collaborative partners
- Rīga Stradiņš University
- Health Research Institute of Asturias (lead)
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
- The Rhodense Territorial Social Health Authority (ASST)
- Hungarian Centre of Excellence for Molecular Medicine
- Augsburg University
Keywords
- Epigenomics
- Multi-omics
- Trained Immunity
- Immunonutrition Diet
- Neoplasms
- Translational Research
Field of Science
- 3.3 Health sciences
Smart Specialization Area
- Biomedicine, medical technologies and biotechnology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.